Seattle runs one of the densest concentrations of federally funded clinical research in the country, and a draft federal policy now in its comment window would give every one of those studies a communications obligation it has never formally had. For anyone responsible for Seattle medical research video production, that is the most important thing to understand about 2027 budgets: the question is shifting from whether to explain a study’s results to the public, to how you hand those results back to the people who enrolled in it.

Table of contents

• Why Seattle research communications is about to get a deadline
• What the draft NIH policy actually says, and what it does not
• Where video fits NIH’s definition of plain language
• The three timelines that would set your production calendar
• Filming on a Seattle research campus
• Build a repeatable results format, not a one off film
• How we approach Seattle medical research video production
• Frequently asked questions

Why Seattle research communications is about to get a deadline

Washington institutions took in NIH funded awards totaling $1.26 billion in fiscal year 2025, supporting 11,537 jobs and $3.06 billion in economic activity, according to United for Medical Research figures compiled in a 2026 Washington state fact sheet from the Association of American Cancer Institutes. That money is not spread evenly across the state. It concentrates in a handful of Seattle campuses.

Fred Hutchinson Cancer Center is a Seattle nonprofit research institute that also serves as the cancer program for UW Medicine. Seattle Children’s Research Institute occupies its own research buildings north of downtown. The Benaroya Research Institute at Virginia Mason runs immune system studies on First Hill. UW Medicine’s research operations extend through South Lake Union, a few blocks from the Allen Institute and the Institute for Systems Biology. The same fact sheet projects 48,590 new cancer cases among Washington residents in 2026, which gives you a rough sense of the trial recruitment pipeline these institutions are feeding.

Put a new federal requirement on NIH supported clinical research and Seattle feels it faster than almost anywhere else, simply because more studies per square mile fall inside the scope. That is the practical case for treating Seattle medical research video production as infrastructure rather than as an occasional marketing expense.

What the draft NIH policy actually says, and what it does not

On September 25, 2026, NIH published the Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants in the Federal Register at 91 FR 60972. The companion NIH Guide notice is NOT-OD-26-113.

Read the status line carefully before you plan anything around it. The Federal Register action is a Request for Information. This is a draft, not a final rule, and the policy’s own applicability date is still a bracketed placeholder set to six months after publication of a final policy. NIH is accepting public comments through October 26, 2026, and the notice says comments are voluntary and may be submitted anonymously. If your institution has a view on formats, that window is the moment to use it.

What the draft would require is straightforward in outline. NIH supported researchers would have to share summary level study results in plain language with research participants. The draft defines summary level study results as a concise overview of a study after all data are compiled and analyzed, covering objective, conduct, methodology as appropriate, cumulative outcomes or key findings, relevance, limitations and potential implications.

The scope is deliberately wide. The draft states that the policy “applies to all clinical research, including clinical trials, supported in whole or in part by NIH, regardless of NIH funding level or funding mechanism, including the NIH Intramural Research Program.” Participants would have to be offered results whether or not they choose to receive them. Exceptions are possible where sharing is justifiably not appropriate, but they require approval from the funding NIH Institute, Center or Office, and the draft is explicit that if no exception is requested, or an exception is not approved, sharing is required.

Three things are not settled: whether a final policy issues at all, when it would take effect, and what format and reading level requirements would accompany it. Anyone telling you the video spec is now fixed is ahead of the document.

Where video fits NIH’s definition of plain language

This is the detail that matters most for production planning, and it is easy to miss. The draft does not define plain language as plain writing. It defines it as “communication, including written, verbal, visual, and other methods, that is clear, concise, well-organized, and follows best practices for communicating with public audiences appropriate to the research topic or field, culture, and context.”

Written, verbal and visual. A narrated two minute explainer in which the principal investigator states what the study asked, what it found and what it does not yet show sits comfortably inside that definition. So does a captioned animation of a mechanism. So does a plain letter.

Be precise about what that means, though. The draft does not require video, does not mention video, and sets no reading level or accessibility standard. What it does is leave the door open, and the Request for Information actively asks about “key elements that are most important to include, helpful formats, and strategies to promote understanding.” Video is one permitted answer among several, not a mandate. Any vendor pitching you a compliance product on the claim that NIH now requires film is misreading the notice.

The honest argument for video here is not legal, it is practical. Participant populations in a metro like Seattle are multilingual and span a wide range of health literacy. A single filmed explainer can be subtitled into several languages, delivered by email or portal, and reused across a study’s sites, which is harder to achieve with a bespoke letter per cohort.

The three timelines that would set your production calendar

The draft sets different clocks for different kinds of work, and they do not line up. If you are scoping Seattle medical research video production across a portfolio of studies, these are the three dates that would drive scheduling.

• Clinical trials. Results would be due no later than one year after the primary completion date, or by the date results must be reported in ClinicalTrials.gov under NIH Grants Policy Statement 4.1.3.1 or NIH Policy Manual Chapter 3007, whichever is later. For most trials that is the binding date.
• Extramural research that is not a clinical trial. Results would be due no later than the end of the period of performance, provided the analyses needed to finalize them are complete. If the analyses are not finished, the draft requires a status update to NIH and to participants instead.
• Intramural projects. Researchers would provide annual status updates telling participants when, where and how they will receive results, beginning no later than six months after the policy effective date.

Two operational consequences follow. First, the trigger is the analysis calendar, not the communications calendar, so production has to be bookable on relatively short notice once a dataset locks. Second, extramural institutions would confirm to NIH that results were shared, or that a status update was provided, through the Research Performance Progress Report at closeout. That makes the deliverable an audit item, which in turn means file naming, dates and distribution records matter as much as the edit.

Filming on a Seattle research campus

The constraint on a research shoot is rarely the crew. It is access, consent and the small set of things that cannot appear in frame.

Laboratory and clinical space is scheduled around the science, not around a camera. Practically, that means short, pre blocked windows, a crew small enough to work inside a corridor or a bench bay, and a shot list agreed with the lab manager before the day. We build these days to be interruptible, because the alternative is a half finished interview and a researcher who will not sit again.

Consent is the part teams underestimate. A results summary film is not a recruitment film, and it is not patient education, so it may route through a different approval path at your institution. Identifiable participants, protected health information on a screen or whiteboard, unpublished data on a monitor, and third party samples all need a decision before the shoot rather than in the edit. The cleanest research films are usually the ones where the principal investigator, the communications lead and whoever owns regulatory sign off were in the same conversation a week early.

One Seattle specific note. Research institutions here hold a lot of symposia and investigator meetings, and the economics of a shoot improve substantially when a results explainer is captured during a week when faculty are already on camera for something else. We cover that kind of multi day academic programming as Seattle conference session libraries, and the marginal cost of adding a results interview to an existing setup is small.

Build a repeatable results format, not a one off film

If a final policy lands close to the draft, the obligation is not one film. It is a film per study, recurring, for as long as the institution holds NIH awards. That argues strongly against treating each one as a bespoke creative project.

The approach that survives volume looks like this. Agree one template: a fixed length, a fixed order of questions, a title card system that takes a study name and a date, and a caption and subtitle workflow. Shoot investigators in batches against a consistent setup. Keep the graphics package parametric so a new set of findings does not mean a new design. Then the per study cost falls to an interview, a graphics pass and a localization pass.

Two more points worth building in from the start. Keep an accessible version as the default rather than the afterthought, because captions and a transcript are cheap at the point of production and expensive to retrofit across a back catalogue. And keep the internal version in mind: the same interview that explains a finding to participants usually answers the question staff are asking too, which is the kind of overlap we use when planning internal communications video for Seattle teams.

NIH is candid that none of this is free. The draft notes that sharing results, while integral to the research process, will incur costs, and it gives no figures and names no funding mechanism. Build the line item now, while the comment window is still open, rather than discovering it in a closeout report.

How we approach Seattle medical research video production

We film clinicians and scientists explaining technical work to non specialist audiences, which is the same craft problem a results summary presents. Here is a film we produced with IQity, in which Dr. Inder Paul Singh explains innovation in glaucoma care to a general audience.

That is the register a results explainer needs: a credentialed voice, plain sentences, no overclaiming, and a clear statement of what remains unknown. You can see more of this work in our portfolio, and the full picture of what our Seattle video production studio covers across the metro, from Downtown and South Lake Union to Bellevue and Redmond, on our Seattle video production page.

Tone Films works across 45 U.S. cities and holds a perfect 5.0 rating across more than 2,500 Google reviews. For research communications specifically, the capability that matters is multi day, multi camera coverage with fast turnaround and enough compliance literacy to know which questions to ask before the camera is switched on.

Frequently asked questions

Does the draft NIH policy require us to make a video?

No. The draft requires summary level results to be shared in plain language, and its definition of plain language covers written, verbal, visual and other methods. Video is one permitted format, not a requirement. The notice does not mention video at all, and no format or reading level standard has been set.

When would this start applying to our studies?

The draft’s applicability date is an unfilled placeholder set at six months after publication of a final policy, so no firm date exists yet. As written, it would apply to competing applications, competitive revisions and new clinical research contracts received on or after that date, and to intramural projects conducted on or after it. Comments on the draft close October 26, 2026.

Who has to approve a results summary film before participants see it?

That depends on your institution, and it is worth settling early because the route often differs from the one a recruitment video takes. Expect the principal investigator, a communications or public affairs lead, and whoever owns human subjects and privacy sign off to be involved. If you intend not to share results at all, the draft routes that through an exception request approved by the funding NIH Institute, Center or Office.

Can one film serve a multi site study coordinated from Seattle?

Usually yes, and it is the cheaper path. Shoot a modular master, keep site specific detail in swappable segments and lower thirds, and subtitle rather than re record for language access. That way a single approval covers the core film and only the short site segments need separate review.

How should we budget for this before NIH says who pays?

Conservatively, and per study rather than per year. NIH has acknowledged that sharing results will incur costs without naming figures or a funding mechanism, so the realistic planning assumption is that it comes out of existing award and institutional communications budgets. A fixed template with batched interviews is the main lever on unit cost.

Start with the study that finishes first

You do not need a policy decision to begin. Find the NIH supported study in your portfolio with the nearest primary completion date, draft the plain language summary your team would want to hand its participants, and work out what it would take to deliver that as something people actually watch. That single exercise tells you more about your institution’s readiness than any vendor deck will.

If it would help to have a production partner in the room for that conversation, get in touch with our Seattle team. We will tell you honestly whether film is the right format for a given study, or whether a well written letter does the job.

About the author

Andrei Tone is the founder and director of Tone Films, a video production company with studios in 45 U.S. cities. He has directed films for police and fire departments, 9-1-1 districts, school districts, hospitals and brands including Disney Junior and Cuisine Solutions.